163 related articles for article (PubMed ID: 3798417)
1. A latex immunoassay of fibrin/fibrinogen degradation products in plasma using a monoclonal antibody.
Mirshahi M; Soria J; Soria C; Perrot JY; Boucheix C
Thromb Res; 1986 Dec; 44(6):715-28. PubMed ID: 3798417
[TBL] [Abstract][Full Text] [Related]
2. Measurement of plasma fibrin D-dimer levels with the use of a monoclonal antibody coupled to latex beads.
Greenberg CS; Devine DV; McCrae KM
Am J Clin Pathol; 1987 Jan; 87(1):94-100. PubMed ID: 3541576
[TBL] [Abstract][Full Text] [Related]
3. New enzyme immunoassay of fibrin-fibrinogen degradation products in plasma using a monoclonal antibody.
Koopman J; Haverkate F; Koppert P; Nieuwenhuizen W; Brommer EJ; Van der Werf WG
J Lab Clin Med; 1987 Jan; 109(1):75-84. PubMed ID: 3540164
[TBL] [Abstract][Full Text] [Related]
4. A monoclonal antibody-based enzyme immunoassay for fibrin degradation products in plasma.
Koppert PW; Hoegee-de Nobel E; Nieuwenhuizen W
Thromb Haemost; 1988 Apr; 59(2):310-5. PubMed ID: 3133813
[TBL] [Abstract][Full Text] [Related]
5. [Clinical evaluation of a test for plasma fibrin/fibrinogen degradation products (FDP) based on monoclonal anti-FDP antibody technology: an application for the scoring system of the disseminated intravascular coagulation (DIC) diagnostic criteria].
Ito K; Wada H; Abe Y; Tomatsu H; Nishioka J; Nobori T
Rinsho Byori; 2003 Apr; 51(4):295-9. PubMed ID: 12747249
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of a latex test for determining the fibrinogen/fibrin D-dimer (XDP)].
Barsotti A; Savarino A
Quad Sclavo Diagn; 1987 Dec; 23(4):421-4. PubMed ID: 3508302
[TBL] [Abstract][Full Text] [Related]
7. Rapid detection of cross-linked fibrin degradation products in plasma using monoclonal antibody-coated latex particles.
Elms MJ; Bunce IH; Bundesen PG; Rylatt DB; Webber AJ; Masci PP; Whitaker AN
Am J Clin Pathol; 1986 Mar; 85(3):360-4. PubMed ID: 2875646
[TBL] [Abstract][Full Text] [Related]
8. Measurement of crosslinked fibrin degradation products - an immunoassay using monoclonal antibodies.
Elms MJ; Bunce IH; Bundesen PG; Rylatt DB; Webber AJ; Masci PP; Whitaker AN
Thromb Haemost; 1983 Aug; 50(2):591-4. PubMed ID: 6356456
[TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of whole blood D-dimer test to plasma D-dimer test for diagnosis of disseminated intravascular coagulation.
Gupta PK; Gupta M; Chatterjee T; Saxena R
Indian J Exp Biol; 2005 Apr; 43(4):382-4. PubMed ID: 15875726
[TBL] [Abstract][Full Text] [Related]
10. [Quantitative analysis of crosslinked fibrin degradation products (XDP) in several diseases].
Saito M; Asakura H; Ito K; Joukaji H; Uotani C; Kumabashiri I; Matsuda T
Rinsho Ketsueki; 1988 Nov; 29(11):2042-7. PubMed ID: 3236412
[No Abstract] [Full Text] [Related]
11. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies to different neo-epitopes on fibrinogen and fibrin degradation products.
Amiral J; Grosley M; Mimilla F; Plassart V; Chambrette B
Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):447-52. PubMed ID: 1723302
[TBL] [Abstract][Full Text] [Related]
13. [Comparative evaluation of D-dimer assays].
Ikematsu S; Kuroso K
Rinsho Byori; 1989 Apr; Spec No 81():189-97. PubMed ID: 2666686
[No Abstract] [Full Text] [Related]
14. Validation, calibration, and specificity of quantitative D-dimer assays.
Dempfle CE
Semin Vasc Med; 2005 Nov; 5(4):315-20. PubMed ID: 16302152
[TBL] [Abstract][Full Text] [Related]
15. False-positive reaction for fibrin degradation products due to a monoclonal (IgM lambda) cryoglobulin with warm-reactive antibody activity for rabbit IgG.
Hammouda W; Moroz LA
Am J Med; 1987 Jun; 82(6):1263-8. PubMed ID: 2440301
[TBL] [Abstract][Full Text] [Related]
16. An immunoassay for human D dimer using monoclonal antibodies.
Rylatt DB; Blake AS; Cottis LE; Massingham DA; Fletcher WA; Masci PP; Whitaker AN; Elms M; Bunce I; Webber AJ
Thromb Res; 1983 Sep; 31(6):767-78. PubMed ID: 6359576
[TBL] [Abstract][Full Text] [Related]
17. [Assay of products of fibrin and fibrinogen degradation in disseminated intravascular coagulations. Evaluation of a new technique].
Borschneck C; Dreyfus M; Bridey F; Edouard D; Meyer D
Presse Med; 1995 May 6-13; 24(17):799-802. PubMed ID: 7630868
[TBL] [Abstract][Full Text] [Related]
18. Measurement of soluble fibrin monomer-fibrinogen complex in plasmas derived from patients with various underlying clinical situations.
Nakahara K; Kazahaya Y; Shintani Y; Yamazumi K; Eguchi Y; Koga S; Wada H; Matsuda M
Thromb Haemost; 2003 May; 89(5):832-6. PubMed ID: 12719780
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of D Dimer analysis in blood coagulation and fibrinolysis tests].
Kurokawa I; Kondo H
Nihon Rinsho; 1989 Dec; 48 Suppl():901-5. PubMed ID: 2695675
[No Abstract] [Full Text] [Related]
20. Measurement of cross linked fibrin derivatives in plasma: an immunoassay using monoclonal antibodies.
Whitaker AN; Elms MJ; Masci PP; Bundesen PG; Rylatt DB; Webber AJ; Bunce IH
J Clin Pathol; 1984 Aug; 37(8):882-7. PubMed ID: 6206097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]